Suchergebnisse - "COVID-19, Coronavirus Disease 2019"

PubPharm (696)

81

Latent class analysis : an innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the intensive care unit

enthalten in: IJID regions | 2022

von Sigwadhi, L. | Tamuzi, J. | Zemlin, A. | +15

82

Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19

enthalten in: European journal of medicinal chemistry reports | 2022

von Dinda, B. | Dinda, M. | Dinda, S. | +1

83

Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish Population

enthalten in: Human gene (Amsterdam, Netherlands) | 2022

von Ali, H. | Niranji, S. | Al-Jaf, S.

84

Randomized placebo-controlled trial of oral tannin supplementation on COVID-19 symptoms, gut dysbiosis and cytokine response

enthalten in: Journal of functional foods | 2022

von Molino, S. | Pisarevsky, A. | Badu, S. | +14

85

Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease

enthalten in: Medicina clinica (English ed.) | 2022

von Qutob, H. | Saad, R. | Bali, H. | +7

86

Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function

enthalten in: Matrix biology plus | 2022

von Pretorius, D. | Richter, R. | Anand, T. | +2

87

Machine learning and comorbidity network analysis for hospitalized patients with COVID-19 in a city in Southern Brazil

enthalten in: Smart health (Amsterdam, Netherlands) | 2022

von Passarelli-Araujo, H. | Passarelli-Araujo, H. | Urbano, M. | +1

88

Coronavirus disease 2019 epidemic prediction in Shanghai under the "dynamic zero-COVID policy" using time-dependent SEAIQR model

enthalten in: Journal of biosafety and biosecurity | 2022

von Ma, Y. | Xu, S. | An, Q. | +8

89

Increased social media utilization and content creation by cardiothoracic surgery programs during the coronavirus disease 2019 pandemic

enthalten in: JTCVS open | 2022

von Gadelkarim, M. | Alrahmani, L. | Tonelli, C. | +5

90

Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19

enthalten in: Mayo Clinic proceedings. Innovations, quality & outcomes | 2022

von Raychaudhuri, D. | Bandopadhyay, P. | D'Rozario, R. | +11